Total Parenteral Nutrition

临床试验

计划入组 163 人 · 首次发布于 2016 年 3 月 11 日

招募中

NCT07414576

AI-driven Total Parenteral Nutrition Platform

计划入组 260 人 · 首次发布于 2026 年 2 月 17 日

终止

NCT00031135

Total Parenteral Nutrition-Associated Liver Disease

计划入组 48 人 · 首次发布于 2002 年 2 月 27 日

药物

查看全部 118 →

Total Parenteral Nutrition

Small Molecule

Approved

Sodium iodide(Sclerodine)

相关疾病：Abscesses, Bleeding of the Vitreal Body，另有 3 项

INa

Small Molecule

Approved

Gluconic Acid(Isolyte S, Isolyte S pH 7.4, Isoplate, Normosol-R, Physiolyte, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasmalyte A)

相关疾病：Fluid Loss, Shock, Hemorrhagic，另有 2 项

C₆H₁₂O₇

机构

查看全部 108 →

Teva Parenteral Medicines, Inc.

United States

Total Metals Corp

United States

TOTAL OPERATIONS MANAGEMENT LLC

United States

资讯

查看全部 4632 →

去年

Multiple Hospitalizations and Disease Duration Emerge as Major Risk Factors for Gallstones in Crohn's Disease

去年

CorMedix Announces Positive Preliminary Q4 2024 Results and Business Updates

4个月前

临床试验

Insulin in Total Parenteral Nutrition

AI-driven Total Parenteral Nutrition Platform

Total Parenteral Nutrition-Associated Liver Disease

药物

Total Parenteral Nutrition

Sodium iodide(Sclerodine)

Gluconic Acid(Isolyte S, Isolyte S pH 7.4, Isoplate, Normosol-R, Physiolyte, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasmalyte A)

机构

Teva Parenteral Medicines, Inc.

Total Metals Corp

TOTAL OPERATIONS MANAGEMENT LLC

资讯

Multiple Hospitalizations and Disease Duration Emerge as Major Risk Factors for Gallstones in Crohn's Disease

CorMedix Announces Positive Preliminary Q4 2024 Results and Business Updates

Jaguar Health Reports Promising Results for Crofelemer in Rare Pediatric Intestinal Failure Conditions